Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Cipla
Farmers Insurance
Queensland Health
Federal Trade Commission
Covington
Johnson and Johnson
US Army
Citi
Moodys

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,940,731

« Back to Dashboard

Summary for Patent: 4,940,731
Title: Method of treating premature ejaculation using sertraline
Abstract:A method of treating premature ejaculation comprising administering to a human in need of such treatment an amount of the compound (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenam ine, also known by the generic name sertraline, or a pharmaceutically acceptable salt thereof, effective in delaying ejaculation.
Inventor(s): Bick; Peter A. (Hartsdale, NY)
Assignee: Pfizer Inc. (New York, NY)
Application Number:07/400,417
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 4,940,731

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 4,940,731

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 110958 ➤ Try a Free Trial
Australia 609664 ➤ Try a Free Trial
Canada 2024188 ➤ Try a Free Trial
Cyprus 1973 ➤ Try a Free Trial
Germany 69012261 ➤ Try a Free Trial
Denmark 0415613 ➤ Try a Free Trial
European Patent Office 0415613 ➤ Try a Free Trial
Hong Kong 219196 ➤ Try a Free Trial
Hungary 213474 ➤ Try a Free Trial
Hungary 905682 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Cantor Fitzgerald
Federal Trade Commission
Express Scripts
Johnson and Johnson
Cerilliant
US Army
Medtronic
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot